GENELABS TECHNOLOGIES INC /CA
10-K405/A, EX-27, 2000-06-21
PHARMACEUTICAL PREPARATIONS
Previous: GENELABS TECHNOLOGIES INC /CA, 10-K405/A, EX-23.01, 2000-06-21
Next: GENELABS TECHNOLOGIES INC /CA, S-3/A, 2000-06-21



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED BALANCE SHEET AS OF DECEMBER 31, 1999 AND THE CONSOLIDATED
STATEMENT OF OPERATIONS FOR THE YEAR ENDED DECEMBER 31, 1999, AND NOTES THERETO,
AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               DEC-31-1999
<CASH>                                           2,534
<SECURITIES>                                     5,565
<RECEIVABLES>                                       60
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                 8,570
<PP&E>                                           9,935
<DEPRECIATION>                                   8,229
<TOTAL-ASSETS>                                  11,689
<CURRENT-LIABILITIES>                            5,560
<BONDS>                                              0
                                0
                                      9,682
<COMMON>                                       139,207
<OTHER-SE>                                   (143,318)
<TOTAL-LIABILITY-AND-EQUITY>                    11,689
<SALES>                                              0
<TOTAL-REVENUES>                                 8,017
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                18,657
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               (501)
<INCOME-PRETAX>                               (10,139)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                           (10,139)
<DISCONTINUED>                                 (2,682)
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (12,821)
<EPS-BASIC>                                     (0.32)
<EPS-DILUTED>                                   (0.32)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission